Home Heart Transplant Sex and Heart Drugs; CMS Rejects Transplant Program; Heart Monitor for Cancer Survivors

Sex and Heart Drugs; CMS Rejects Transplant Program; Heart Monitor for Cancer Survivors

3 min read

A review in ESC Heart Failure argues that new therapies need to be better tested in women (included <30% of the time in trials) and that guidelines need to better reflect sexual dimorphism in heart failure presentation.

Bay Labs announced they will launch the EchoMD AutoEF software after receiving FDA permission. The software uses artificial intelligence to automatically select the best clips and performs calculations of left ventricular ejection fraction.

The Institute for Clinical and Economic Review is working on a cost-effectiveness analysis of canakinumab for cardiovascular risk management in patients with atherosclerosis.

Medicare will no longer fund St. Luke's Heart Transplant Program in Houston. Officials from the Centers for Medicare and Medicaid Services claim St. Luke's hasn't done enough to rectify issues adversely affecting patients. (ProPublica)

The FDA granted permission to begin marketing two catheter-based devices to make an arteriovenous fistula in patients with chronic kidney disease undergoing hemodialysis for treatment. "Dialysis is a necessary and life-saving procedure for thousands of individuals. With today's action, there will be additional, less-invasive vascular access options for patients who will require hemodialysis," said Bram Zuckerman, MD, director of the Division of Cardiovascular Devices at the FDA.

Investigators at Cedars-Sinai discovered a new cellular mechanism for how arterial inflammation leads to atherosclerosis.

Childhood cancer survivors who underwent chemotherapy might benefit from Vivio, a new handheld device used to identify heart complications. "The pediatric oncology community is becoming increasingly aware that there are new issues faced by many cancer survivors that may not manifest themselves until decades after their cancer treatment is done," said Saro Armenian, DO, MPH, director of the Childhood Cancer Survivorship Clinic at City of Hope, in a press release. "One of these issues is a higher burden of cardiovascular disease, which can result from exposure to anthracyclines [a class of chemotherapy] as part of their cancer treatment."

Time to register for the European Society of Cardiology (ESC) Congress 2018, to be held August 25-29 in Munich. Learn about the latest advances in cardiovascular science and how they might affect the way you care for your patients.

2018-06-25T12:30:00-0400

Source link

Check Also

How beef benefits heart health, muscle mass & brain function

If you’re over the age of 50, how does your health factor into your daily decisions about …